Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

A Study to Evaluate Safety and Efficacy of Elagolix in Participants With Endometriosis With Associated Moderate to Severe Pain

ClinicalTrials.gov ID: NCT03343067

Public ClinicalTrials.gov record NCT03343067. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 6:36 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Study to Evaluate Safety and Efficacy of Elagolix Alone or Elagolix With Hormonal Add-Back in Subjects With Endometriosis With Associated Moderate to Severe Pain

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a Phase 3, dose-escalation study designed to evaluate the safety and efficacy of both elagolix alone and elagolix plus estradiol/norethindrone acetate (E2/NETA) over 24 months in the management of endometriosis with associated moderate to severe pain in premenopausal women.

Study identification

NCT ID
NCT03343067
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
AbbVie
Industry
Enrollment
11 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 49 Years
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 27, 2017 (Actual)
Primary completion
Oct 23, 2018 (Actual)
Completion
Oct 23, 2018 (Actual)
Last update posted
Nov 27, 2019

2017 – 2018

United States locations

U.S. sites
37
U.S. states
19
U.S. cities
33
Facility City State ZIP Site status
Pinnacle Research Group /ID# 202016 Anniston Alabama 36207 —
Noble Clinical Research /ID# 170628 Tucson Arizona 85704 —
Lynn Institute of the Ozarks /ID# 165052 Little Rock Arkansas 72205 —
SC Clinical Research /ID# 165049 Garden Grove California 92844 —
Marvel Clinical Research /ID# 169633 Huntington Beach California 92647 —
Health care Affiliates Medical Group /ID# 165048 Santa Ana California 92704 —
Western States Clinical Res /ID# 169809 Wheat Ridge Colorado 80033-2896 —
Nova Clinical Research, LLC /ID# 202227 Bradenton Florida 34209-4616 —
Midland Florida Clinical Research Center /ID# 201327 DeLand Florida 32720-0920 —
Southeastern Integrated Med /ID# 203109 Gainesville Florida 32607 —
Care Partners Clinical Researc /ID# 168395 Jacksonville Florida 32277 —
LCC Medical Research Institute /ID# 168888 Miami Florida 33126 —
A Premier Clinical Research of Florida, LLC /ID# 201887 Orange City Florida 32763-2833 —
GCP Clinical Research, LLC /ID# 169774 Tampa Florida 33609-4044 —
Triple O Research Institute /ID# 201128 West Palm Beach Florida 33407-3100 —
Bingham Memorial Hospital /ID# 170110 Blackfoot Idaho 83221 —
Leavitt Womens Healthcare /ID# 169495 Idaho Falls Idaho 83404-8322 —
Quad Clinical Research, LLC /ID# 168294 Chicago Illinois 60605 —
Quad Clinical Research, LLC /ID# 170629 Chicago Illinois 60605 —
Women's Health Care, PC /ID# 165033 Newburgh Indiana 47630-8940 —
Delricht Research /ID# 200219 New Orleans Louisiana 70115 —
Quad Clinical Research, LLC /ID# 200180 St Louis Missouri 63108-3204 —
Montana Health Research Inst /ID# 170624 Billings Montana 59102 —
Excel Clinical Research /ID# 170620 Las Vegas Nevada 89109 —
Northwell health system /ID# 200162 Manhasset New York 11030-3816 —
Radiant Research, Inc /ID# 200045 Akron Ohio 44311 —
Central Ohio Clinical Research /ID# 170750 Columbus Ohio 43213-3399 —
Optimed Research /ID# 167642 Columbus Ohio 43235 —
VitaLink Research /ID# 168401 Greenville South Carolina 29601 —
VitaLink Research /ID# 170625 Greenville South Carolina 29601 —
Fusion Clinical Research of Spartanburg /ID# 200010 Spartanburg South Carolina 29301-5642 —
Centex Studies, Inc /ID# 169897 Houston Texas 77058-2705 —
America's Adv. Wellness Center /ID# 170005 Houston Texas 77080 —
ClinRx Research, LLC /ID# 201189 Plano Texas 75024-5280 —
Progressive Clinical Research /ID# 205565 San Antonio Texas 78229 —
Eastern Virginia Med School /ID# 165016 Norfolk Virginia 23507-1627 —
Seattle Reproductive Medicine /ID# 171079 Seattle Washington 98109 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03343067, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 27, 2019 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03343067 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →